Top Markets
#1 PulseChain PulseChain +45.01%
#2 RedStone RedStone +18.29%
#3 Glidr Glidr +11.78%
#4 SkyAI SkyAI +10.14%
#5 Bitway Bitway +9.91%
#6 OPENLOOT OPENLOOT +8.85%
#7 Pump.fun Pump.fun +7.99%
#8 Unit Pump Unit Pump +7.99%
#9 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.84%
#10 Monad Monad +6.79%
Coin of the day
PulseChain PulseChain
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Hisse Senetlerindeki Sıralama #28046
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Hisse Fiyatı
$0.55
Son senkronizasyon: 2025-02-11
Piyasa Değeri
$28.90M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Marinus Pharmaceuticals, Inc. (MRNS)

Kategori

Healthcare
Marinus Pharmaceuticals, Inc. (MRNS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.55 - 2025-02-01

Gün sonu en düşük fiyat: $8.00 - 2014-07-01
Marinus Pharmaceuticals, Inc. için hisse fiyatı geçmişi: 2014 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2025 81.15%
2024 -86.72%
2023 124.80%
2022 -63.10%
2021 -18.02%
2020 95.30%
2019 -53.99%
2018 -51.67%
2017 728.84%
2016 -86.53%
2015 -16.46%
2014 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.11 -14.02%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 5.84%
CH